Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
Jun 13, 2026
ImmunityBio's stock took a hit as the FDA flagged its cancer drug promotion as misleading. Investors bailed, but what does this mean for the biotech's future?